Royalty Pharma plc (RPRX) |
| 58.265 0.085 (0.15%) 07-20 11:27 |
| Open: | 58.34 |
| High: | 58.95 |
| Low: | 58.18 |
| Volume: | 781,914 |
| Market Cap: | 25,061(M) |
| PE Ratio: | 11.49 |
| Exchange: | NASDAQ |
| Industry: | Medical - Pharmaceuticals |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 69.43 |
| Resistance 1: | 59.44 |
| Pivot price: | 57.17 |
| Support 1: | 54.32 |
| Support 2: | 51.15 |
| 52w High: | 59.44 |
| 52w Low: | 34.081 |
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Financials
| EPS | 1.900 |
| Book Value | 15.530 |
| PEG Ratio | 2.18 |
| Gross Profit | 6.339 |
| Profit Margin (%) | 33.86 |
| Operating Margin (%) | 100.30 |
| Return on Assets (ttm) | 5.5 |
| Return on Equity (ttm) | 13.8 |
Company news
Mon, 20 Jul 2026
Hsbc Holdings PLC Acquires 1,486,020 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Mon, 20 Jul 2026
Royalty Pharma declares $0.235 dividend - MSN
Fri, 17 Jul 2026
Royalty Pharma declares $0.235 quarterly dividend - Investing.com
Fri, 17 Jul 2026
Royalty Pharma Announces Third Quarter 2026 Dividend of $0.235 per Class A Ordinary Share - Quiver Quantitative
Fri, 17 Jul 2026
Royalty Pharma dividend arrives Sept. 10 for Aug. 14 record-date holders - Stock Titan
Fri, 17 Jul 2026
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High - Here's Why - MarketBeat
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
